Necitumumab (anti-EGFR) | EGFR | Read Reviews & Product Use Citations

Necitumumab (anti-EGFR) is an epidermal growth factor receptor (EGFR) antagonist that can be used in combination with gemcitabine and cisplatin for the first-line treatment of patients with metastatic squamous non-small cell lung cancer.

Click to purchase the isotype control of Necitumumab (anti-EGFR)

Purity & Quality Control

Batch: A204801 Purity: 98% Protein concentration: 4.6mg/ml Endotoxin Level: <1 EU/mg

98

Choose Selective EGFR Inhibitors

Biological Activity

Description	Necitumumab (anti-EGFR) is an epidermal growth factor receptor (EGFR) antagonist that can be used in combination with gemcitabine and cisplatin for the first-line treatment of patients with metastatic squamous non-small cell lung cancer.

Product Details

CAS No.	906805-06-9
Molecular Weight	150 kDa
Isotype	human IGg1, κ
Application	Necitumumab (anti-EGFR)
Source	CHO
Purification	Protein G
Sterility	0.2 μM filtered
Formulation	PBS Buffer, PH 7.4
Storage (From the date of receipt)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field